| Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ... Jama 316 (2), 171-181, 2016 | 1706 | 2016 |
| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1033 | 2019 |
| Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi L Tenthani, AD Haas, H Tweya, A Jahn, JJ Van Oosterhout, ... Aids 28 (4), 589-598, 2014 | 425 | 2014 |
| Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population G Wandeler, LF Johnson, M Egger Current Opinion in HIV and AIDS 11 (5), 492-500, 2016 | 414 | 2016 |
| Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic G Wandeler, T Gsponer, A Bregenzer, HF Günthard, O Clerc, A Calmy, ... Clinical Infectious Diseases 55 (10), 1408-1416, 2012 | 348 | 2012 |
| Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub‐Saharan Africa: systematic review and meta‐analysis C Mugglin, J Estill, G Wandeler, N Bender, M Egger, T Gsponer, O Keiser, ... Tropical Medicine & International Health 17 (12), 1509-1520, 2012 | 296 | 2012 |
| Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis C Wettstein, C Mugglin, M Egger, N Blaser, LS Vizcaya, J Estill, N Bender, ... Aids 26 (18), 2361-2373, 2012 | 219 | 2012 |
| Determinants of HIV-1 broadly neutralizing antibody induction P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ... Nature medicine 22 (11), 1260-1267, 2016 | 177 | 2016 |
| Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions EC Caniglia, LE Cain, A Justice, J Tate, R Logan, C Sabin, A Winston, ... Neurology 83 (2), 134-141, 2014 | 156 | 2014 |
| Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study B Bertisch, S Franceschi, M Lise, P Vernazza, O Keiser, F Schöni-Affolter, ... American journal of epidemiology 178 (6), 877-884, 2013 | 155 | 2013 |
| Hepatitis delta-associated mortality in HIV/HBV-coinfected patients C Béguelin, D Moradpour, R Sahli, F Suter-Riniker, A Lüthi, M Cavassini, ... Journal of hepatology 66 (2), 297-303, 2017 | 142 | 2017 |
| Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis AD Haas, O Keiser, E Balestre, S Brown, E Bissagnene, C Chimbetete, ... The lancet HIV 2 (7), e271-e278, 2015 | 110 | 2015 |
| Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection GM Clifford, M Lise, S Franceschi, M Egger, C Bouchardy, D Korol, F Levi, ... British journal of cancer 106 (3), 447-452, 2012 | 103 | 2012 |
| Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study G Wandeler, T Gsponer, F Bihl, E Bernasconi, M Cavassini, H Kovari, ... The Journal of infectious diseases 208 (9), 1454-1458, 2013 | 102 | 2013 |
| Outcomes of antiretroviral treatment programs in rural Southern Africa G Wandeler, O Keiser, K Pfeiffer, S Pestilli, C Fritz, ND Labhardt, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (2), e9-e16, 2012 | 99 | 2012 |
| Hepatitis C virus transmission among human immunodeficiency virus‐infected men who have sex with men: modeling the effect of behavioral and treatment interventions L Salazar‐Vizcaya, RD Kouyos, C Zahnd, G Wandeler, M Battegay, ... Hepatology 64 (6), 1856-1869, 2016 | 98 | 2016 |
| Weight and metabolic changes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people living with HIV: a cohort study B Surial, C Mugglin, A Calmy, M Cavassini, HF Günthard, M Stöckle, ... Annals of internal medicine 174 (6), 758-767, 2021 | 92 | 2021 |
| Cohort profile update: the Swiss HIV cohort study (SHCS) AU Scherrer, A Traytel, DL Braun, A Calmy, M Battegay, M Cavassini, ... International journal of epidemiology 51 (1), 33-34j, 2022 | 84 | 2022 |
| Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia L Mulenga, P Musonda, A Mwango, MJ Vinikoor, MA Davies, A Mweemba, ... Clinical infectious diseases 58 (10), 1473-1480, 2014 | 80 | 2014 |
| Effectiveness of protease inhibitor/nucleos (t) ide reverse transcriptase inhibitor–based second-line antiretroviral therapy for the treatment of human immunodeficiency virus … AJ Stockdale, MJ Saunders, MA Boyd, LJ Bonnett, V Johnston, ... Clinical infectious diseases 66 (12), 1846-1857, 2018 | 77 | 2018 |
